Antiglucocorticoid drugs in the treatment of depression.
about
Opposite effects of early maternal deprivation on neurogenesis in male versus female ratsChronic Stress-induced Hippocampal Vulnerability: The Glucocorticoid Vulnerability HypothesisAntiglucocorticoid treatments for mood disordersAntiglucocorticoid treatments for mood disordersAntiglucocorticoid treatments in mood disorders: efficacy and safetyGlucocorticoid dysregulations and their clinical correlates. From receptors to therapeuticsNeurobiology of chronic mild stress: parallels to major depressionGlucocorticoid inhibition in the treatment of depression: can we think outside the endocrine hypothalamus?Angst and the amygdalaAntidepressants are a rational complementary therapy for the treatment of Alzheimer's disease.Effect of chronic administration of selective glucocorticoid receptor antagonists on the rat hypothalamic-pituitary-adrenocortical axis.Long-term corticosterone exposure decreases insulin sensitivity and induces depressive-like behaviour in the C57BL/6NCrl mouse.Recent developments in the psychobiology and pharmacotherapy of depression: optimising existing treatments and novel approaches for the future.Treatments in depression.11beta-hydroxysteroid dehydrogenase type 1 as a novel therapeutic target in metabolic and neurodegenerative disease.Trends in the development of new antidepressants. Is there a light at the end of the tunnel?Neuroendocrine predictors of the evolution of depression.The physiology of human glucocorticoid receptor beta (hGRbeta) and glucocorticoid resistance.Tissue production of cortisol by 11beta-hydroxysteroid dehydrogenase type 1 and metabolic disease.Thiazolidinediones: novel treatments for cognitive deficits in mood disorders?Beyond the monoaminergic hypothesis: agomelatine, a new antidepressant with an innovative mechanism of action.Therapeutic armamentarium for treating depression.Obesity and mental illness: implications for cognitive functioning.Quantitative analysis of RU38486 (mifepristone) by HPLC triple quadrupole mass spectrometry.Screening genetic variability at the CNR1 gene in both major depression etiology and clinical response to citalopram treatment.The missing link between clinical states and biomarkers in mental disorders.
P2860
Q21144216-17E1E285-0AB3-4466-BFAE-1E4FCF275CB7Q21651040-2A30AAEC-08FE-4C26-9D2E-24ED321A98CCQ24187372-BE1E05DB-9A2F-4205-B98A-AB41598931ECQ24242845-646B9341-11AF-4BA9-9AC9-53CBEB05FFACQ24245324-E4FB17DB-AEB7-4C60-AA37-0AAC6B624DB4Q24618470-DFA53CDC-D8A3-41FD-A7FF-3923234448C3Q27026698-3B5F0787-A6B3-4ADE-AF09-F08A49811624Q30454937-F792D769-C6DE-4A0E-98DB-63F9DB5C9C11Q30473413-C4949777-5E05-4C20-8F7D-2DD9B15255CDQ33751924-C9CE8D3B-009D-461C-BC1D-137D49108F5FQ34191282-C7D92391-5894-4300-936F-8AB1FB1C38F7Q34331553-AB4D15E0-ACD4-41F1-9CC1-667CA5874871Q35040802-0434523C-6EC8-46EF-A7E4-A8973E9A334DQ35236696-A433651D-2426-4660-A19D-7544BABD919BQ35593949-0412D752-4F04-4090-B682-D278EEF00812Q35743638-A12659BA-5912-4E92-A8E5-9FE57005A61DQ36255135-004CE5CC-CC9C-4539-9BA8-EB3798572564Q36541281-14AF088A-D2AC-4FA7-BA10-6BAB0FF705FCQ36674845-4D401DE7-50BD-4B1B-81E3-8DA2D1769C54Q36904879-6D3D5131-9AC5-4502-97D0-536F9452F73EQ37405307-BAF9D7BA-0232-4B1F-A13F-930F9ED8DC2EQ37777008-F7C64B35-CDE1-4012-876A-D560F0F318E5Q38120446-E4C5E506-F7A7-4367-89BC-E7A1AEC83F57Q39495334-760DEC08-B707-41DF-B523-5D5C05215E41Q45754167-5348B843-7C42-447D-B46B-9EE57C5A8420Q48606448-1A816789-E677-4B6B-8B64-0B790A9C5917
P2860
Antiglucocorticoid drugs in the treatment of depression.
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Antiglucocorticoid drugs in the treatment of depression.
@ast
Antiglucocorticoid drugs in the treatment of depression.
@en
Antiglucocorticoid drugs in the treatment of depression.
@nl
type
label
Antiglucocorticoid drugs in the treatment of depression.
@ast
Antiglucocorticoid drugs in the treatment of depression.
@en
Antiglucocorticoid drugs in the treatment of depression.
@nl
prefLabel
Antiglucocorticoid drugs in the treatment of depression.
@ast
Antiglucocorticoid drugs in the treatment of depression.
@en
Antiglucocorticoid drugs in the treatment of depression.
@nl
P2860
P1476
Antiglucocorticoid drugs in the treatment of depression.
@en
P2093
P2860
P304
P356
10.1517/13543784.10.10.1789
P407
P577
2001-10-01T00:00:00Z